2-substituted proline bis-amide orexin receptor antagonists

Details for Australian Patent Application No. 2007272795 (hide)

Owner Merck & Co., Inc.

Inventors Breslin, Michael J.; Whitman, David B.; Cox, Christopher D.

Agent Spruson & Ferguson

Pub. Number AU-A-2007272795

PCT Pub. Number WO2008/008551

Priority 60/831,177 14.07.06 US

Filing date 13 July 2007

Wipo publication date 17 January 2008

International Classifications

A61K 31/401 (2006.01) - Proline

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/008551 Priority application(s): WO2008/008551

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272804-Attenuation of reperfusion injury

2007272785-Methods to elicit, enhance and sustain immune responses against MHC class1 restricted epitopes, for prophylactic or therapeutic purposes